Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience
Authors:
- 1 September 2007
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 20 (9) , 747-753
Abstract
Orthotopic liver transplantation (OLT) is increasingly being applied for cure in patients with cirrhosis and concomitant hepatocellular carcinoma (HCC). In recipients with limited tumor burden, OLT achieves reasonable long-term outcome. This study sought to identify clinical and pathologic variables predictive of long-term disease-free survival and the presence of vascular invasion. From 1992 to 2006, 130 patients underwent OLT for cirrhosis and HCC. Malignancy was diagnosed in 107 patients prior to OLT and in 23 patients on pathologic examination of the explant. Nine clinical and pathologic variables were considered including: TNM stage, nodularity, vascular invasion, Milan criteria, incidental lesion, differentiation, tumor size, preOLT transarterial chemoembolization (TACE), and administration of sirolimus-based immunosuppression. The overall incidence of HCC recurrence was 17% with the majority (82%) being stage III. Cumulatively, tumor recurrence-free survival (RFS) is 84, 74, and 67% at 1, 3, and 5 years respectively. Independent predictors of RFS included stage III and poorly differentiated lesions (P3.5 cm in size were predictive of vascular invasion. Importantly, preOLT, TACE and postOLT sirolimus had no influence on survival. Pathologic variables including tumor stage and grade have a significant impact on outcome. Importantly, it seems that TACE and sirolimus had no beneficial effect.Keywords
This publication has 28 references indexed in Scilit:
- Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantationTransplant International, 2006
- Liver Transplantation and Recurrent Hepatocellular Carcinoma: Predictive Value of Nodule Size in a Retrospective and Explant StudyTransplantation, 2006
- Long-term efficacy of percutaneous thermal ablation for patients with recurrent hepatocellular carcinomaNature Clinical Practice Gastroenterology & Hepatology, 2006
- Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2005
- Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinomaLiver Transplantation, 2005
- Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis CLiver Transplantation, 2004
- Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policyLiver Transplantation, 2004
- Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 2001
- The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot studyHepatology, 1997
- Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 1995